Guardant Health (GH) Change in Receivables (2017 - 2026)

Guardant Health (GH) has 10 years of Change in Receivables data on file, last reported at -$942000.0 in Q1 2026.

• Quarterly Change in Receivables fell 115.4% year-over-year to -$942000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.1 million (down 33.43% YoY) and the FY2025 annual result came in at $28.2 million, up 31.73% from the prior year.
• Change in Receivables slipped to -$942000.0 in Q1 2026 per GH's latest filing, from $22.2 million in the prior quarter.
• The five-year high for Change in Receivables was $22.2 million in Q4 2025, with the low at -$14.5 million in Q3 2025.
• Average Change in Receivables over 5 years is $2.3 million, with a median of $1.7 million recorded in 2023.
• The widest YoY moves for Change in Receivables: up 120683.33% in 2024, down 616.19% in 2024.
• Guardant Health's Change in Receivables stood at $11.1 million in 2022, then sank by 100.16% to -$18000.0 in 2023, then surged by 120683.33% to $21.7 million in 2024, then gained by 2.3% to $22.2 million in 2025, then sank by 104.24% to -$942000.0 in 2026.
• Business Quant data shows GH's Change in Receivables at -$942000.0 in Q1 2026, $22.2 million in Q4 2025, and -$14.5 million in Q3 2025.